Tumour necrosis factor-alpha mediates blood-brain barrier damage in HIV-1 infection of the central nervous system.
The pathogenesis of brain inflammation and damage by human immunodeficiency virus (HIV) infection is unclear. Because blood-brain barrier damage and impaired cerebral perfusion are common features of HIV-1 infection, we evaluated the role of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) in mediating disruption of the blood-brain barrier. Levels of TNF-alpha were more elevated in cerebrospinal fluid (CSF) than in serum of HIV-1 infected patients and were mainly detected in those patients who had neurologic involvement. Intrathecal TNF-alpha levels correlated with signs of blood-brain barrier damage, manifested by high CSF to serum albumin quotient, and with the degree of barrier impairment. In contrast, intrathecal IL-1beta levels did not correlate with blood-brain barrier damage in HIV-1 infected patients. TNF-alpha seems to be related to active neural inflammation and to blood-brain barrier damage. The proinflammatory effects of TNF-alpha in the nervous system are dissociated from those of IL-1beta.
Sharief
M K
MK
Department of Neurochemistry Institute of Neurology The National Hospital for Neurology and Neurosurgery Queen Square London WC1N 3BG UK.
Ciardi
M
M
Thompson
E J
EJ
Sorice
F
F
Rossi
F
F
Vullo
V
V
Cirelli
A
A